Drug Approval | April 05, 2022
Abott gets USFDA approval for leadless pacemaker
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
Subscribe To Our Newsletter & Stay Updated
